2020-21 indirect tax collections beat revised estimates by 8%: CBIC Chief

Out of the total provisional indirect tax collections, custom duty collections came in at Rs 1.32 lakh crore, excise and service tax collections came at Rs 3.91 lakh crore, while the net GST collection for the centre stood at Rs 5.48 lakh crore.

Arup Roychoudhury

April 13, 2021 / 15:49 IST

Union Finance Ministry. (PC-PTI)

The provisional net indirect tax collections for 2020-21 came in at Rs 10.71 lakh crore, compared with revised estimates of Rs 9.89 lakh crore, M Ajit Kumar, Chairman of Central Board of Indirect Taxes and Customs, said on April 13.

“Provisional net indirect tax revenue collections including GST, customs, central excise and service tax arrears for FY 2020-21 stood at Rs 10.71 lakh crore, registering more than 12 percent growth year-on-year. Revised estimates for FY 2020-21 have been exceeded by 8.2 percent,” Kumar said while addressing a media briefing.

Out of the total provisional indirect tax collections, custom duty collections came in at Rs 1.32 lakh crore versus a revised target of Rs 1.12 lakh crore and excise and service tax collections came at Rs 3.91 lakh crore as against a target of 3.62 lakh crore. Kumar said that diesel and petrol excise duties were the biggest contributors to excise duties.

Revised estimates of net GST collection including CGST and compensation cess for FY 2020-21 was Rs 5.15 lakh crore while net GST Collection for the centre stood at Rs 5.48 Lakh Crore.

"In recent months, the net indirect tax collection have shown robustness. Most of the sector of the economy have bounced back after a difficult phase. metals, white goods, automobiles, cement, chemicals, electronics have shown good growth. This is sign of green shoot in the economy," Kumar said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show